# Hydroxychloroquine in Giant Cell Arteritis

> **NCT00430807** · PHASE3 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 75 (actual)

## Conditions studied

- Giant Cell Arteritis

## Interventions

- **DRUG:** hydroxychloroquine/placebo

## Key facts

- **NCT ID:** NCT00430807
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2005-01
- **Final completion:** 2006-12
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2015-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00430807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00430807, "Hydroxychloroquine in Giant Cell Arteritis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00430807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*